You have free access to this content

Cancer Cytopathology

Cover image for Vol. 119 Issue 6

25 December 2011

Volume 119, Issue 6

Pages 355–424

  1. CytoSource

    1. Top of page
    2. CytoSource
    3. Editorials
    4. Original Articles
    5. Thanks to Authors and Peer Reviewers
    1. You have free access to this content
  2. Editorials

    1. Top of page
    2. CytoSource
    3. Editorials
    4. Original Articles
    5. Thanks to Authors and Peer Reviewers
    1. You have free access to this content
      Rapid prescreening in gynecologic cytology : A more efficient quality assurance method (pages 357–360)

      Manon Auger

      Article first published online: 22 SEP 2011 | DOI: 10.1002/cncy.20189

      Rapid prescreening is an underutilized strategy for gynecologic cytology. The study by Tavares et al published in the current issue of Cancer Cytopathology adds strong data to the growing body of evidence that rapid prescreening is an excellent internal quality assurance method for improving the performance of gynecologic cytology.

  3. Original Articles

    1. Top of page
    2. CytoSource
    3. Editorials
    4. Original Articles
    5. Thanks to Authors and Peer Reviewers
    1. You have free access to this content
      Maximizing the yield of lymph node cytology : Lessons learned from rapid onsite evaluation of image- and endoscopic-guided biopsies of hilar and mediastinal lymph nodes (pages 361–366)

      Gilda da Cunha Santos, Scott L. Boerner and William R. Geddie

      Article first published online: 29 JUN 2011 | DOI: 10.1002/cncy.20166

      • original image

      This commentary focuses on the use of rapid onsite evaluation in computed tomography-guided and endobronchial ultrasound-guided transbronchial needle aspiration procedures. The authors describe their process for triaging and handling hilar and mediastinal lymph node aspirates to maximize cell recovery to meet the current demand for the use of multiple ancillary techniques and molecular analyses in thoracic oncology.

    2. You have free access to this content
      Improvement in the routine screening of cervical smears : A study using rapid prescreening and 100% rapid review as internal quality control methods (pages 367–376)

      Suelene Brito Nascimento Tavares, Nadja L. Alves de Sousa, Edna J. C. Manrique, Zair B. Pinheiro de Albuquerque, Luiz C. Zeferino and Rita G. Amaral

      Article first published online: 22 SEP 2011 | DOI: 10.1002/cncy.20190

      Rapid prescreening performed better than 100% rapid review of negative smears as a method of internal quality control of cervical cytology exams. This method permits constant evaluation of the sensitivity of prescreeners and routine reviewers and provides assurance that the rate of false-negative results in cytology remains within minimum acceptable levels.

    3. You have free access to this content
      Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high–grade squamous intraepithelial lesion papanicolaou test results (pages 377–386)

      Faye F. Gao, R. Marshall Austin and Chengquan Zhao

      Article first published online: 19 JUL 2011 | DOI: 10.1002/cncy.20176

      • original image

      The incidence of cervical intraepithelial neoplasia (CIN) 2/3+ follow-up was significantly higher with human papillomavirus (HPV)-positive high-grade squamous intraepithelial lesion (HSIL) than with HPV-negative HSIL. Some HPV-negative HSIL cases may have represented HSIL cytologic mimics.

    4. You have free access to this content
      Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China (pages 387–394)

      Fang-Hui Zhao, Shang-Ying Hu, Jessica J. Bian, Bin Liu, Roger B. Peck, Yan-Ping Bao, Qin-Jing Pan, Lucien Frappart, John Sellors and You-Lin Qiao

      Article first published online: 19 JUL 2011 | DOI: 10.1002/cncy.20177

      • original image

      In this comparison of ThinPrep and SurePath liquid-based cytology (LBC), both methods yielded similar validity in detecting significant cervical lesions. However, SurePath samples yielded higher rates of satisfactory LBC slides and sufficient residual volume for Hybrid Capture 2.

    5. You have free access to this content
      A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non–muscle-invasive urothelial cell carcinoma : A prospective study (pages 395–403)

      Ana B. Galván, Marta Salido, Blanca Espinet, José Placer, Lara Pijuan, Núria Juanpere, Josep Lloreta, Francesc Solé and Antoni Gelabert-Mas

      Article first published online: 29 JUN 2011 | DOI: 10.1002/cncy.20168

      • original image

      Fluorescence in situ hybridization (FISH) analysis with the UroVysion assay demonstrated a high sensitivity and specificity in the monitoring of non–muscle-invasive bladder tumors, similar to cystoscopy and higher than cytology. Given these results, the authors propose that FISH could be a useful monitoring tool in the surveillance of patients with a previous history of bladder cancer.

    6. You have free access to this content
      Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology (pages 404–410)

      Coya Tapia, Kathrina Glatz, Ellen C. Obermann, Bruno Grilli, Audrey Barascud, Michelle Herzog, René Schönegg, Spasenija Savic and Lukas Bubendorf

      Article first published online: 5 JUL 2011 | DOI: 10.1002/cncy.20171

      • original image
      • original image

      The high frequency of chromosomal polysomies in reactive urothelial cells is a potential source of false-positive fluorescence in situ hybridization results. Cells with a polyploid chromosomal pattern are of limited diagnostic value and should be interpreted in synopsis with the morphology and patient's medical history because they are common in reactive conditions.

    7. You have free access to this content
      Diagnostic and prognostic information obtained on fine-needle aspirates of primary neuroblastic tumors : Proposal for a Cytology Prognostic Score (pages 411–423)

      Jerzy Klijanienko, Jérôme Couturier, Hervé Brisse, Gaëlle Pierron, Paul Fréneaux, Frédérique Berger, Zofia Maciorowski, Xavier Sastre-Garau, Jean Michon and Gudrun Schleiermacher

      Article first published online: 19 JUL 2011 | DOI: 10.1002/cncy.20173

      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image
      • original image

      Fine-needle aspiration material is suitable for diagnosis and genomic techniques in patients with neuroblastoma. It also may be used for cytology prognostic scoring.

  4. Thanks to Authors and Peer Reviewers

    1. Top of page
    2. CytoSource
    3. Editorials
    4. Original Articles
    5. Thanks to Authors and Peer Reviewers
    1. You have free access to this content

SEARCH

SEARCH BY CITATION